Utpal Koppikar - Jul 9, 2021 Form 3 Insider Report for Flexion Therapeutics Inc (FLXN)

Role
Director
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Stock symbol
FLXN
Transactions as of
Jul 9, 2021
Transactions value $
$0
Form type
3
Date filed
7/12/2021, 04:04 PM
Previous filing
Jun 9, 2021
Next filing
Aug 19, 2021

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.